Lee Capital Holdings’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-10,000
Closed -$603K 83
2020
Q3
$603K Hold
10,000
0.35% 52
2020
Q2
$588K Hold
10,000
0.54% 40
2020
Q1
$557K Buy
+10,000
New +$611K 0.46% 47

Other funds holding BMY

Lee Capital Holdings's BMY Position: Q4 2020 in Review

Lee Capital Holdings sold out of Bristol-Myers Squibb (BMY) in Q4 2020, closing a stake of 10,000 shares — an estimated $603K sold.

Lee Capital Holdings first reported a position in BMY in Q1 2020 and held it in 3 quarters. The position peaked at $603K in Q3 2020. 2,359 funds tracked by Wall St. Rank hold BMY as of Q4 2020.

  • Lee Capital Holdings reported no remaining Bristol-Myers Squibb position as of Q4 2020 after selling out during the quarter.
  • Lee Capital Holdings sold 10,000 Bristol-Myers Squibb shares in Q4 2020, an estimated $603K.
  • Lee Capital Holdings first reported a position in Bristol-Myers Squibb in Q1 2020 and held it in 3 quarters.
  • Lee Capital Holdings's Bristol-Myers Squibb position peaked at $603K in Q3 2020.
  • 2,359 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.

Based on Lee Capital Holdings's 13F filing for Q4 2020, filed 16 Feb 2021.